Gabe S. Sonke
The Netherlands Cancer Institute(NL)Oncode Institute(NL)Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital(NL)Amsterdam University of the Arts(NL)University of Amsterdam(NL)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Ovarian cancer diagnosis and treatment, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, PARP inhibition in cancer therapy
Most-Cited Works
- → Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer(2018)2,759 cited
- → AACR Project GENIE: Powering Precision Medicine through an International Consortium(2017)1,958 cited
- → Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer(2016)1,956 cited
- → Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial(2017)1,842 cited
- → Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer(2018)1,373 cited
- → Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: MONALEESA-3(2018)1,086 cited